Showing results (251-260 of 386) with videos related to
Sort By:
Pageof 39
Carcinogenesis|October 16, 2013
Genome-wide analysis associates familial colorectal cancer with increases in copy number variations and a rare structural variation at 12p12.3Rongxi Yang, Bowang Chen, Katrin Pfütze, et al.BMC Cancer|August 10, 2019
Investigating the effects of additional truncating variants in DNA-repair genes on breast cancer risk in BRCA1-positive womenIlnaz Sepahi, Ulrike Faust, Marc Sturm, et al.Ophthalmology|May 3, 2018
Systemic and Ocular Determinants of Peripapillary Retinal Nerve Fiber Layer Thickness Measurements in the European Eye Epidemiology (E3) PopulationMatthias M Mauschitz, Pieter W M Bonnemaijer, Kersten Diers, et al.JAMA|June 14, 2012
Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trialFrank M Brunkhorst, Michael Oppert, Gernot Marx, et al.BMC Cancer|March 9, 2018
Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer historyChristoph Engel, Kerstin Rhiem, Eric Hahnen, et al.International Journal of Cancer|July 20, 2020
The "unnatural" history of colorectal cancer in Lynch syndrome: Lessons from colonoscopy surveillanceAysel Ahadova, Toni T Seppälä, Christoph Engel, et al.Zeitschrift Fur Gastroenterologie|November 19, 2019
[Current recommendations for surveillance, risk reduction and therapy in Lynch syndrome patients]Robert Hüneburg, Stefan Aretz, Reinhard Büttner, et al.Human Mutation|October 16, 2009
Identification of a DMBT1 polymorphism associated with increased breast cancer risk and decreased promoter activitySandrine Tchatchou, Angela Riedel, Stefan Lyer, et al.Intensive Care Medicine|May 4, 2017
Effect of a multifaceted educational intervention for anti-infectious measures on sepsis mortality: a cluster randomized trialFrank Bloos, Hendrik Rüddel, Daniel Thomas-Rüddel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2012
Risks of less common cancers in proven mutation carriers with lynch syndromeChristoph Engel, Markus Loeffler, Verena Steinke, et al.Pageof 39